Jim Simons
VERA icon

Jim Simons’s Vera Therapeutics VERA Stock Holding History

Jim Simons’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.4M Buy
457,300
+263,900
+136% +$11.4M 0.03% 685
2025
Q4 		$9.79M Buy
+193,400
New +$6.87M 0.02% 925
2025
Q2 		– Sell
-40,600
Closed -$975K – 3930
2025
Q1 		$975K Buy
40,600
+4,900
+14% +$157K ﹤0.01% 2446
2024
Q4 		$1.51M Buy
+35,700
New +$1.58M ﹤0.01% 2231
2024
Q3 		– Sell
-147,800
Closed -$5.35M – 3918
2024
Q2 		$5.35M Buy
147,800
+32,800
+29% +$1.3M 0.01% 1252
2024
Q1 		$4.96M Buy
+115,000
New +$4.1M 0.01% 1411
2023
Q4 		– Sell
-87,200
Closed -$1.2M – 4162
2023
Q3 		$1.2M Buy
+87,200
New +$1.5M ﹤0.01% 2182
2023
Q2 		– Sell
-174,800
Closed -$1.36M – 4287
2023
Q1 		$1.36M Buy
174,800
+149,900
+602% +$1.16M ﹤0.01% 2264
2022
Q4 		$482K Buy
+24,900
New +$451K ﹤0.01% 2968

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jim Simons's VERA Position: Q1 2026 in Review

Jim Simons increased its Vera Therapeutics (VERA) stake by 136% in Q1 2026, buying an estimated $11.4M and bringing the position to 457,300 shares worth $18.4M. The position accounts for 0.03% of the portfolio, ranked #685.

Jim Simons first reported a position in VERA in Q4 2022 and has held it in 9 quarters since. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • Jim Simons held 457,300 shares of Vera Therapeutics worth $18.4M as of Q1 2026.
  • Jim Simons bought 263,900 Vera Therapeutics shares in Q1 2026, an estimated $11.4M.
  • Vera Therapeutics made up 0.03% of Jim Simons's portfolio in Q1 2026, its #685 holding.
  • Jim Simons first reported a position in Vera Therapeutics in Q4 2022 and has held it in 9 quarters since.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.